MREO - Mereo BioPharma Group plc

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Income statement
Cash flow
Annual

Balance sheet

Currency in GBP. All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
56,334
94,296
23,469
16,347
Other short-term investments
-
-
-
0
Total cash
56,334
94,296
23,469
16,347
Total current assets
62,131
99,323
29,726
30,435
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
3,359
4,108
3,384
13,252
Accumulated depreciation
-1,528
-1,578
-1,811
-1,694
Net property, plant and equipment
1,831
2,530
1,573
11,558
Intangible assets
24,116
24,564
31,648
44,456
Total non-current assets
25,947
27,094
33,221
56,014
Total assets
88,078
126,417
62,947
86,449
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
11,085
-
-
15,139
Accounts payable
3,078
2,285
3,333
6,352
Accrued liabilities
4,491
3,826
4,178
5,138
Other current liabilities
735
1,269
-
354
Total current liabilities
24,677
12,541
8,565
29,878
Non-current liabilities
Long-term debt
-
14,384
16,142
5,373
Other long-term liabilities
182
80
62
44
Total non-current liabilities
1,533
25,874
69,353
16,315
Total liabilities
26,210
38,415
77,918
46,193
Stockholders' equity
Common stock
1,875
1,755
1,017
294
Retained earnings
-331,164
-296,968
-309,693
-146,065
Accumulated other comprehensive income
137,912
136,895
133,225
47,319
Total stockholders' equity
61,868
88,002
-14,971
40,256
Total liabilities and stockholders' equity
88,078
126,417
62,947
86,449